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ABSTRACT
The World Health Organization recently recognized 
the Republic of Kosovo as one of the highest consumers 
per capita of antibiotics for human use among non-
European Union Eastern European countries; however, 
data are limited regarding antimicrobial usage and 
antimicrobial resistance in the livestock sector for this 
recently formed country. The objective of this study 
was to conduct the first nationwide survey of anti-
microbial resistance phenotypes in indicator bacteria 
collected from dairy farms in Kosovo. Composite fecal 
samples were collected from 52 farms located within 
all 7 administrative districts of Kosovo in the summer 
of 2014. Isolation and characterization of the indicator 
bacteria Escherichia coli (n = 165) and Enterococcus 
spp. (n = 153) from these samples was achieved by cul-
turing on selective/differential media with and without 
select antibiotics, followed by MALDI-TOF (matrix-
assisted laser desorption/ionization time-of-flight) mass 
spectrometry-based identification and antimicrobial 
susceptibility testing using the disk diffusion method. 
When no selective pressure was applied in culture-based 
isolation, the majority of E. coli and Enterococcus spp. 
collected were resistant to ≤1 of 16 and ≤2 of 12 anti-
biotics tested, respectively. In contrast, E. coli and En-
terococcus spp. isolated using sub-minimum inhibitory 
concentrations of cefoxitin, ciprofloxacin, or erythromy-
cin were typically resistant to at least one and often 
multiple antibiotic types, which primarily consisted of 
certain β-lactams, quinolones, sulfonamides, phenicols, 
and tetracyclines for E. coli isolates and macrolides, 
tetracyclines, and rifamycins for enterococci isolates.
Key words: antimicrobial resistance, Escherichia coli, 
Enterococcus spp., Kosovo
Short Communication
Antimicrobial resistance (AMR) is expected to be 
one of the greatest challenges faced by animal agricul-
ture and public health (US CDC, 2013; WHO, 2014). 
Globally, large quantities of antimicrobials are used for 
human therapy and agricultural applications, promot-
ing AMR development in the diverse microbial com-
munities associated with these systems (US CDC, 2013; 
US FDA-NARMS, 2014; US FDA, 2016). Animal pro-
duction is recognized as the primary agricultural driver 
of AMR, as antimicrobials are administered therapeuti-
cally, prophylactically, and for growth promotion (US 
FDA-NARMS, 2014; US FDA, 2016). When coupled 
with estimates of increased antimicrobial use in coun-
tries with growing animal production over the next 
decade, this suggests further expansion of the livestock-
associated AMR threat (Van Boeckel et al., 2015).
The AMR problem is largely unaddressed in low- to 
middle-income countries, exposing critical gaps within 
AMR monitoring and mitigation networks (Founou et 
al., 2016). Countries with weak or inadequate national 
policies, regulation, and surveillance systems were 
identified by the World Health Organization (WHO) 
to be at increased risk for producing AMR bacteria 
as well as for dissemination of these bacteria interna-
tionally (WHO, 2014). The Republic of Kosovo is a 
recently formed country in the Balkan Peninsula of 
Europe. A lack of regional collaboration, coordination, 
and resources have limited Kosovo’s ability to control 
the use of antimicrobials and monitor AMR. Estimates 
compiled by the WHO ranked Kosovo’s population to 
be the fourth highest consumer of antibiotics among 
13 non-European Union Eastern European countries 
surveyed, with the majority of human antibiotic use 
attributed to β-lactams (including cephalosporins), 
quinolones, macrolides, and sulfonamides (Versporten 
et al., 2014). Knowledge of AMR in Kosovo’s livestock 
sector is more limited, but β-lactams, sulfonamides, 
and tetracyclines are reported to be the most widely 
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administered antibiotics in Kosovo’s cattle (Sulejmani 
et al., 2012; Gallina et al., 2013), and 3 studies suggest 
this use may be reflected in the AMR phenotypes of 
associated bacteria (Mehmeti et al., 2015; Hamidi and 
Sylejmani, 2016; Mehmeti et al., 2016).
The objective of this study was to conduct the first 
nationwide survey of priority AMR phenotypes within 
the indicator bacteria Escherichia coli and Enterococ-
cus spp. collected from dairy farms in Kosovo. These 
bacteria were specifically chosen for analyses because 
they are reported to have antimicrobial susceptibility 
fingerprints that are somewhat reflective of net anti-
biotic exposure in their environment (Harwood et al., 
2000; Lillehaug et al., 2005), resistance determinants 
found within these genera can be associated with mo-
bile genetic elements (Frye and Jackson, 2013), and 
these bacteria are used to broadly represent resistance 
trends for gram-negative and gram-positive organisms 
in animal production, respectively (US FDA-NARMS, 
2014).
A 2014 agricultural census indicated that 134,393 
head of dairy cattle are present within 63,874 agricul-
tural holdings in Kosovo’s 7 administrative districts 
(ASK, 2015). The population of dairy cows and agri-
cultural holdings within these districts were reported 
as Prishtinё (28,834 cows, 14,592 holdings), Mitrovicё 
(16,740 cows, 8,159 holdings), Pejё (21,856 cows, 8,889 
holdings), Prizren (22,862 cows, 12,252 holdings), Fer-
izaj (11,673 cows, 6,359 holdings), Gjilan (12,623 cows, 
5,005 holdings), and Gjakovё (19,805 cows, 8,168 hold-
ings; ASK, 2015). Although not specifically classified 
in the agricultural census, a 2007 report indicates the 
average dairy herd size in Kosovo was 1.6 head per 
agricultural holding, indicating the majority of dairy 
farms were for subsistence (US AID, 2007). Only 6% 
of Kosovo’s dairy farms were classified as commercial 
operations (defined as ≥5 head per holding; US AID, 
2007).
In this study, E. coli and Enterococcus spp. were iso-
lated from composite fecal samples, collected from 52 
commercial dairy farms intentionally selected to cover 
all 7 administrative districts of Kosovo in July 2014 
(Table 1). Farm accessibility, herd size (≥5 animals), 
and geographic distribution were the primary factors 
used to direct sampling efforts. The sample was not 
randomly selected, and so summary values from it 
cannot be formally used as estimates of countrywide 
parameters; we provide them as conjectural estimates 
only. Logistic regression was used to determine the 
odds ratio of target isolates displaying AMR to the pri-
ority antibiotics tested in this study [cefoxitin (FOX); 
ciprofloxacin (CIP), and erythromycin (ERY)] to 3 
epidemiological variables including herd size, breed, 
and sampling location. A 95% confidence interval was 
used to assess correlation of multidrug resistance of 
isolates with herd size, breed, and sampling location. 
Herd size was rescaled (size divided by 10) for analysis 
so that a 1-unit increase corresponds to an additional 
10 animals. This is because, for instance, herds of size 
47 and 48 are essentially the same size, whereas 47 
and 57 are appreciably different. All statistical analyses 
were performed using Minitab version 16 (Minitab Inc., 
State College, PA).
The composite fecal samples consisted of 10 fresh in-
dividual fecal samples collected from pen floors (10 fe-
cal samples per farm). Samples were stored on ice until 
laboratory analyses were initiated, which occurred on 
the day of collection. The individual fecal samples were 
homogenized via manual mixing to prepare the com-
posite sample. Composite samples were then directly 
inoculated onto 8 different agar medium formulations, 
which included Enterococcosel agar (ENT; Becton 
Dickinson, Sparks, MD) or MacConkey agar (MAC) 
(Becton Dickinson) with and without supplemented 
sub-MIC of antibiotics, and incubated overnight at 
37°C. The antibiotics used were CIP (Sigma-Aldrich, 
Saint Louis, MO), 1 µg/mL; FOX (Sigma-Aldrich), 4 
µg/mL; and ERY (Sigma-Aldrich), 4 µg/mL. These 
concentrations of antibiotics were specifically chosen to 
minimize microbial stresses in the transition to agar 
media, while still providing limited selective pressure. 
Single isolates were then propagated in brain heart 
infusion broth (Becton Dickinson) overnight at 37°C, 
mixed with 40% glycerol (Sigma-Aldrich), and stored 
at −80°C until further analyses could be performed.
Isolates were confirmed as E. coli or Enterococcus 
spp. by matrix-assisted laser desorption/ionization bio-
typing following a standard formic acid-acetonitrile ex-
traction procedure (Bizzini et al., 2010) using a Bruker 
Microflex LRF mass spectrometer pre-calibrated with 
bacterial test standard operated with Bruker Biotyper 
software (ver. 3.1) (Bruker, Billerica, MA). Species-
level identifications were only accepted if scored ≥2.0 
by the Biotyper algorithm. To examine the resistance 
phenotypes of confirmed E. coli and Enterococcus spp. 
isolates, antimicrobial susceptibility testing using the 
disk diffusion method was performed in accordance with 
Clinical and Laboratory Standards Institute guidelines 
(CLSI, 2015). Specifically, Sensi-Discs (Becton Dickin-
son) were used to evaluate antimicrobial susceptibilities 
to 16 and 12 antibiotics for E. coli and Enterococcus 
spp., respectively. This screening encompassed 11 class-
es of antibiotics for E. coli and 10 classes of antibiotics 
for Enterococcus spp.
The 52 dairy farms sampled in this study contained 
between 5 and 220 head of cattle, primarily of Holstein 
and Simmental breeds, with an average of 32.5 head per 
farm (Table 1). Two farms exclusively reared sheep and 
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goats. All but 8 farms reported antimicrobial use, with 
penicillin (29 farms, 56%) and streptomycin (28 farms, 
54%) being the most frequently reported antimicrobials 
used. Use of gentamicin (4 farms, 8%), oxytetracycline 
(10 farms, 19%), and enrofloxacin (5 farms, 10%) was 
reported on multiple farms sampled.
From a total of 447 presumptive isolates, 165 and 153 
isolates of E. coli and Enterococcus spp. were obtained, 
respectively. Non-E. coli and Enterococcus spp. isolates 
were excluded from additional analyses. Ten different 
species of enterococci were identified, with Enterococcus 
faecalis being the most frequently encountered species 
(n = 63), followed by Enterococcus faecium (n = 44), 
Enterococcus hirae (n = 25), Enterococcus mundtii (n = 
9), Enterococcus pseudoavium (n = 5), and Enterococ-
cus casseliflavus (n = 3). Single isolates of Enterococcus 
gilvus, Enterococcus devriesei, Enterococcus malodora-
tus, and Enterococcus villorum were also collected.
The AMR phenotypes of confirmed E. coli (Table 
2) and Enterococcus spp. isolates (Table 3) were as-
sociated with the antibiotic selective pressure used for 
culture-based isolation. Escherichia coli isolates were 
resistant to as many as 10 antibiotics tested (Table 4), 
belonging to as many as 8 different antibiotic classes 
(Figure 1). Seventy-eight percent of isolates were 
resistant to 2 or fewer antibiotic classes (Figure 1). 
Resistance to multiple antibiotic classes, typically to 
certain β-lactams, quinolones, sulfonamides, phenicols, 
or tetracyclines, was primarily observed when isolates 
were selected using CIP or FOX supplementation of 
the medium used in isolation. Escherichia coli isolated 
on MAC and MAC-ERY were successfully identified 
from 36 (69%) and 45 (87%) farms, respectively. Few 
(<20% of isolates) of the MAC and MAC-ERY isolates 
were resistant to any one of the antibiotics tested, and 
both of these groups had similar antimicrobial suscep-
tibility profiles. Phenotypic similarities between MAC 
and MAC-ERY were not unexpected given that ERY 
and other macrolides are generally not selective against 
members of the Enterobacteriaceae (Phuc Nguyen et 
al., 2009). Escherichia coli isolated from MAC-FOX 
were successfully obtained from 29 (56%) of the farms 
sampled, and of these isolates, ≥20% were resistant to 
amoxicillin-clavulanate (20%), cefazolin (CFZ; 36%), 
FOX (24%), and ampicillin (AMP; 36%). Escherichia 
coli isolates selected using MAC-CIP agar were collect-
ed from 18 (35%) of the farms sampled, and ≥20% of 
these isolates were resistant to amoxicillin-clavulanate 
(30%), CFZ (78%), CIP (91%), sulfamethoxazole/trim-
ethoprim (SXT; 74%), AMP (87%), piperacillin (83%), 
chloramphenicol (52%), nalidixic acid (91%), and TET 
(87%). Little to no resistance (<10% of isolates) was 
observed in any of the E. coli isolates to the amino-
glycosides gentamicin and tobramycin, the carbapenem Ta
b
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imipenem, the third-generation cephalosporins cefotax-
ime and ceftazidime, and the monobactam aztreonam.
Interestingly, of the 22 E. coli dairy isolates obtained 
in this study that were resistant to SXT, 20 were also 
resistant to AMP and TET. Resistance to AMP, SXT, 
and TET is recognized as a core component of multi-
drug resistance patterns in E. coli isolates from multiple 
European countries, potentially reflecting both the past 
use of these antimicrobials and the frequent association 
of the genes conferring resistance to these antimicrobi-
als on the same mobile elements (EFSA and ECDC, 
2017).
Enterococcus spp. isolates were resistant to as many 
as 8 antibiotics tested (Table 5), belonging to as many 
as 6 different antibiotic classes (Figure 1). Of these iso-
lates, 77% were resistant to 2 or fewer antibiotic classes 
(Figure 1). Resistance to multiple antibiotic classes, 
typically to macrolides, tetracyclines, or rifamycins, 
was primarily observed when isolates were selected 
for using ERY in the agar medium. Enterococcus spp. 
isolated on ENT and ENT-FOX were successfully ob-
tained from 31 (60%) and 41 (79%) of farms sampled, 
respectively. Among these isolates, ≥39% were resis-
tant to rifampin (RIF) and ≥23% were resistant to 
quinupristin-dalfopristin (QD). Given that enterococci 
are intrinsically resistant to FOX (Moellering et al., 
1974), it was anticipated that the antimicrobial sus-
ceptibilities in FOX-selected Enterococcus spp. isolates 
would be similar to those from media without antibi-
otic supplementation. In general this was observed, al-
though a slightly greater proportion of isolates derived 
from ENT, compared with isolates from ENT-FOX, 
were resistant to CIP (21 vs. 16% of isolates) and TET 
(21 vs. 14% of isolates). When ENT-CIP was used for 
selection, Enterococcus spp. isolates were successfully 
obtained on 28 (54%) of the farms tested, and ≥20% 
of these isolates were resistant to RIF (67%), CIP 
(52%), and QD (46%). Enterococcus spp. isolated using 
ENT-ERY were found on 15 (29%) of the farms tested, 
and ≥20 of these isolates were resistant to RIF (38%), 
CIP (46%), ERY (100%), chloramphenicol (38%), QD 
(50%), doxycycline (71%), and TET (96%). Little to 
Table 4. Antibiograms of antimicrobial-resistant Escherichia coli isolates from Kosovo dairies
Media (no. of isolates)1  Resisted antibiotics2
MAC-CIP (4)  AMC AMP CAM CFZ CIP NAL PIP SXT TET  
MAC-FOX (1)  AMC AMP CAM CFZ FOX      
MAC-CIP (1)  AMC AMP CFZ CIP GEN NAL PIP SXT TET TOB
MAC-CIP (2)  AMC AMP CFZ CIP NAL PIP TET    
MAC-FOX (5)  AMC AMP CFZ FOX       
MAC-FOX (1), MAC-ERY (1)  AMC AMP CFZ PIP SXT TET     
MAC-FOX (1)  AMC AMP         
MAC-FOX (1)  AMC CFZ FOX        
MAC-CIP (7)  AMP CAM CFZ CIP NAL PIP SXT TET   
MAC-FOX (1)  AMP CAM CFZ FOX GEN PIP     
MAC-FOX (1), MAC-CIP (1)  AMP CAM CFZ FOX       
MAC-ERY (1)  AMP CAM CFZ PIP SXT TET     
MAC-CIP (2)  AMP CFZ CIP NAL PIP SXT TET    
MAC-CIP (1)  AMP CFZ CIP NAL PIP TET     
MAC-FOX (1)  AMP CFZ PIP SXT TET      
MAC-ERY (1)  AMP CFZ PIP TET       
MAC (1), MAC-FOX (1), 
 MAC-ERY (2)
 AMP CFZ PIP        
MAC-FOX (1)  AMP CFZ         
MAC-CIP (2)  AMP CIP NAL PIP SXT TET     
MAC (6), MAC-FOX (3), 
 MAC-ERY (1)
 AMP          
MAC-ERY (1)  AZA          
MAC-FOX (1)  CAM CFZ FOX NAL TET      
MAC (1)  CAM          
MAC (2), MAC-FOX (2), 
 MAC-ERY (1)
 CFZ          
MAC-CIP (2)  CIP FOX GEN NAL SXT      
MAC-CIP (1)  CIP NAL TET        
MAC (1)  CTX          
MAC-ERY (1)  FOX          
MAC (1), MAC-CEF (1), 
 MAC-ERY (4)
 TET          
1MAC = MacConkey agar (Becton Dickinson, Sparks, MD), supplemented with CIP (ciprofloxacin), FOX (cefoxitin), or ERY (erythromycin).
2AMC = amoxicillin-clavulanate; AMP = ampicillin; AZA = aztreonam; CAM = chloramphenicol; CFZ = cefazolin; CTX = cefotaxime; GEN 
= gentamicin; NAL = nalidixic acid; PIP = piperacillin; SXT = sulfamethoxazole/trimethoprim; TET = tetracycline; TOB = tobramycin.
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Figure 1. (A) The number of antibiotic classes resisted by Escherichia coli and Enterococcus spp. isolates. The number of antibiotics resisted 
by (B) E. coli isolates (a total of 16 antibiotics tested) and (C) Enterococcus spp. isolates (a total of 12 antibiotics tested) from media with and 
without supplemented antibiotics. MAC = MacConkey agar (Becton Dickinson, Sparks, MD), ENT = Enterococcosel agar (Becton Dickinson), 
FOX = cefoxitin, CIP = ciprofloxacin, ERY = erythromycin.
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no resistance (<10% of isolates) was observed in any 
of the Enterococcus spp. isolates to FOS, the glycopep-
tide vancomycin, the oxazolidinone linezolid, and the 
β-lactams AMP and penicillin.
Of the epidemiological factors that could possibly be 
related to the priority AMR phenotypes examined here, 
only herd size was significant. The odds of observing 
CIP-resistant E. coli increased by 9% for every 10 addi-
tional cows in a herd (odds ratio of 1.094, 95% CI 1.007 
to 1.188). For Enterococcus spp., the odds of observing 
ERY-resistant isolates increased by 14% for every 10 
additional cows in a herd (odds ratio of 1.142, 95% CI 
1.039 to 1.254).
Improved monitoring is needed to better understand 
the risk associated with the potential transmission of 
AMR bacteria from food animals to humans. In devel-
oping countries, little to no data on AMR or the spread 
and distribution of zoonotic agents are available. This 
study provides the first description of AMR in E. coli 
and Enterococcus spp. isolated from dairy farms across 
a wide geographical area of Kosovo. These isolates from 
dairy animals were shown to contain priority AMR 
phenotypes including cephem, quinolone, and macro-
lide resistance. Additionally, this study contains the 
most comprehensive description of AMR phenotypes 
for any group of bacterial isolates of animal origin col-
lected from Kosovo. Our study provides data on AMR 
in Kosovo's dairy production, which can be used in 
future risk assessment studies of AMR in the country’s 
primary production and to aid in informing policy deci-
sions for agricultural antimicrobial use.
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Table 5. Antibiograms of antimicrobial-resistant Enterococcus spp. isolates from Kosovo dairies
Media (no. of isolates)1  Resisted antibiotics2
ENT-ERY (1)   AMP CAM CIP DOXY ERY PEN QD TET
ENT-ERY (1)   CAM CIP DOXY ERY PEN TET    
ENT (2), ENT-FOX (1), ENT-CIP (1), 
 ENT-ERY (2)
  CAM CIP DOXY ERY QD RIF TET  
ENT-CIP (1), ENT-ERY (1)   CAM CIP DOXY ERY QD TET    
ENT (3), ENT-FOX (3), ENT-CIP (7)   CAM DOXY ERY FOS QD RIF TET  
ENT (1)   CAM DOXY ERY RIF TET      
ENT-ERY (2)   CAM ERY QD TET        
ENT-ERY (2)   CIP DOXY ERY RIF TET      
ENT-ERY (2)   CIP DOXY ERY TET        
ENT-CIP (1), ENT-ERY (3)   CIP DOXY QD RIF TET      
ENT (2)   CIP ERY QD RIF        
ENT-FOX (1)   CIP ERY RIF          
ENT-ERY (1)   CIP QD RIF          
ENT-FOX (1)   CIP RIF            
ENT (1)   CIP              
ENT (3), ENT-FOX (4), ENT-CIP (2)   DOXY ERY FOS TET        
ENT-ERY (3)   DOXY ERY QD RIF TET      
ENT-ERY (3)   DOXY ERY QD TET        
ENT-CIP (1), ENT-ERY (1)   DOXY ERY RIF TET        
ENT-CIP (1)   DOXY ERY TET          
ENT-CIP (1)   DOXY TET            
ENT-CIP (3)   ERY FOS QD TET        
ENT (3), ENT-FOX (2), ENT-CIP (10)   ERY RIF            
ENT-ERY (1)   ERY TET            
ENT-ERY (1)   ERY              
ENT-FOX (1), ENT-ERY (1)   FOS              
ENT-CIP (1)   QD RIF TET          
ENT-CIP (1)   QD RIF            
ENT-FOX (1)   QD TET            
ENT (5), ENT-FOX (2), ENT-CIP (13)   QD              
ENT (3)   RIF TET            
ENT (4), ENT-FOX (10), ENT-CIP (1)   RIF              
ENT (1), ENT-FOX (1), ENT-CIP (1)   TET              
1ENT = Enterococcosel agar (Becton Dickinson, Sparks, MD), supplemented with CIP (ciprofloxacin), FOX (cefoxitin), or ERY (erythromycin).
2AMP = ampicillin; CAM = chloramphenicol; DOXY = doxycycline; FOS = fosfomycin; PEN = penicillin; QD = quinupristin-dalfopristin; RIF 
= rifampin; TET = tetracycline.
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